DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20201835

Idiopathic intracranial hypertension in pregnancy: about a rare case

I. Elamouri, I. Aissaoui, H. Tahiri, H. Saadi, A. Mimouni

Abstract


In this work, study report the case of a 23-year-old primigravidae, in whom an idiopathic intracranial hypertension (IIH), formerly called pseudotumor cerebri, was diagnosed in the first trimester with visual field impairment, the management of which was similar to cases of benign intracranial hypertension in the general population. The parturient put under medical treatment with ophthalmological and obstetrical follow-up until 39 weeks of amenorrhea where she was cesarized for rescue of the visual prognosis. The objective of this work is to elucidate this pathology, caused by a defect of reabsorption of the CSF by the arachnoid plexus. The diagnosis is retained after elimination by radio-biological exploration of an infectious, tumor or traumatic etiology. Idiopathic intracranial hypertension has no impact on the evolution of pregnancy. In addition, the choice of delivery route is dependent on the patient's visual prognosis being brought into play.


Keywords


Benign, Idiopathic, Pregnancy, Visual prognosis

Full Text:

PDF

References


Chazal J, Klein O. Benign intracranial hypertension: history, definition and pathophysiology. Neurosurg. 2008;54(6):704-9.

Jacopin-Bruneau L, Gommier B, Pierre F, Boog G. Mild intracranial hypertension and pregnancy - About two cases. Journal of Obstetrics Gynecology and Reproductive Biology. J Gynécol Obstét Biol Reprod. 2010;39(3):246-50.

Glueck CJ, Iyengar S, Goldenberg N, Smith LS, Wang P. Idiopathic intracranial hypertension: associations with coagulation disorders and polykystic-ovary syndrome. J Lab Clin Med. 2003;142(1):35-45.

Corbett JJ, Digre K. Idiopathic intracranial hypertension, an answer to, “the chicken or the egg”. Neurol. 2002;58:5-6.

Glueck CJ, Aregawi D, Goldenberg N, Golnic KC, Steve L, Wang P. Idiopathic intracranial hypertension, polykystic-ovary syndrome and thrombophilia. J Lab Clin Med. 2005;145:72-82.

Klein O, Joud A, Marchal JC. Management of benign intracranial hypertension: analysis of the Nancy series. Neurosurg. 2008;54(6):710-3.

Katz VL, Peterson R, Cefalo RG. Pseudotumor cerebri and pregnancy. Am J Perinatol. 1989;6:442-5.

Juhan-Vague I, Alessi MC, Morange PE. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. Ann Med. 2000;32:78-84.

Huna-Baron R, Kupersmith MJ. Idiopathic intracranial hypertension in pregnancy. J Neurol. 2002;249:1078-81.

Tang RA. Management of idiopathic intracranial hypertension in pregnancy. Med Gen Med. 2005;7:40.

Bagga R, Jain V, Gupta KR, Gopalan S, Malhotra S. Choice of therapy and mode of delivery in idiopathic intracranial hypertension during pregnancy. Med Gen Med. 2005;7:42.

Lee AG, Pless M, Falardeau J, Capozolli T, Wall M, Kardon RH. The use of acetazolamide in idiopathic intracranial hypertension during pregnancy Am J Ophthalmol. 2005;139:855-9.

Dhellemmes P, Defoort S, Vinchon M. Benign intracranial hypertension: place of medical treatment. Neurosurg. 2008;54(6):717-20.

Tang RA, Dorotheo EU, Schiffman JS, Bahrani HM. Medical and surgical management of idiopathic intracranial hypertension in pregnancy. Curr Neurol Neurosci Rep. 2004;4:398-409.

Corbet JJ, Thompson HS. The rational management of idiopathic intracranial hypertension. Arch Neurol. 1989;46:1049-51.

Metellus P, Levrier O, Fuentes S, N'Doye N, Laghmari M, Adetchessi T, et al. Endovascular treatment of benign intracranial hypertension labeled idiopathic. Analysis of eight consecutive cases. Neurosurg. 2007;53(1):10-7.